Side Navigation

서브 컨텐츠

Kolmar Korea, as Pharmaceutical CMO company, is dedicated to efficient pharmaceutical contract manufacturing project management, quality assurance and analytical services to ensure on-time delivery and assurance of commercial supply.From the development labs to the commercial production stage and business development, we strive to constantly improve how we meet the needs of our clients in a constantly evolving pharmaceutical business landscape.

We are doing to be globalized with CDMO service to the world major companies and multinational company and continuously expanding its export market more based on this.

Business Model can be discussed;

- Exporting Finished products

- Penetration to Korean market

- Contract manufacturing and Packaging

- Joint Venture

- In/Out License

- Co-Development of New Products

In 2012, Kolmar Korea has founded with 2 Joint Venture Companies with Kracie (Japan) and Pharmascience (Canada) which are reliable and leading pharmaceutical companies in countries.

Kraice is based on Japan and does business in traditional herbal pharmaceutical products, toiletary, foods area.

Kolmar and Kracie have established Korea Kracie Pharma Korea in Jan.2013.

Kracie Korea business is to collaborate manufacturing and sales, marketing of traditional herbal medicines and distribute products all over Korean market since 2013.

Pharmascience Korea : JV Company with Pharmascience (Canada), a leading manufacturer of generic drugs in Canada(2012. 11)

Since founded in 2012, Pharmascience(PMS) based on Canada and Kolmar are applying marketing authorization(MA) for several products to KFDA in order to provide more advanced and proven pharmaceutical products in safety and efficacy to Korean market.

On a basis of experience of these partnerships with world class pharmaceutical companies, Kolmar has qualification to expedite new business territories with any companies who want to collaborate together, and we believe that this kind of various partnerships will lead us to one of global CDMO companies.